SG11201900960WA - Composition for ameliorating peripheral nerve disorder caused by anticancer agent - Google Patents

Composition for ameliorating peripheral nerve disorder caused by anticancer agent

Info

Publication number
SG11201900960WA
SG11201900960WA SG11201900960WA SG11201900960WA SG11201900960WA SG 11201900960W A SG11201900960W A SG 11201900960WA SG 11201900960W A SG11201900960W A SG 11201900960WA SG 11201900960W A SG11201900960W A SG 11201900960WA SG 11201900960W A SG11201900960W A SG 11201900960WA
Authority
SG
Singapore
Prior art keywords
anticancer agent
peripheral nerve
disorder caused
nerve disorder
composition
Prior art date
Application number
SG11201900960WA
Inventor
Kentaro Nakamura
Hidekazu Tonouchi
Hideo Nakajima
Mami MURAMATSU
Original Assignee
Meiji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Publication of SG11201900960WA publication Critical patent/SG11201900960WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dairy Products (AREA)

Abstract

CO MPOSITION FOR AMELIORA TING PERIPHERAL NERVE DISORDER CAUSED BY ANTICANCER AGENT 5 The present invention relates toa composition for ameliorating peripheral nerve disorder caused by administr ation of an anticancer agent includ ing a milk protein hydrolysate ,and a protein derived from fermented milk as proteins; a medium - chain fatt y acid or its triglyceride, and an n −3 fatty 10 acid as lipids ; and isomaltulose as a carbohydrate. Fig. 2
SG11201900960WA 2016-08-19 2017-08-18 Composition for ameliorating peripheral nerve disorder caused by anticancer agent SG11201900960WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016161457A JP6325036B2 (en) 2016-08-19 2016-08-19 Composition for improving peripheral neuropathy caused by anticancer agent
PCT/JP2017/029647 WO2018034345A1 (en) 2016-08-19 2017-08-18 Composition for improving peripheral neuropathy caused by anticancer agents

Publications (1)

Publication Number Publication Date
SG11201900960WA true SG11201900960WA (en) 2019-03-28

Family

ID=61196731

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201900960WA SG11201900960WA (en) 2016-08-19 2017-08-18 Composition for ameliorating peripheral nerve disorder caused by anticancer agent

Country Status (5)

Country Link
JP (1) JP6325036B2 (en)
CN (1) CN109641027A (en)
SG (1) SG11201900960WA (en)
TW (1) TWI754662B (en)
WO (1) WO2018034345A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202020104290U1 (en) * 2019-07-24 2020-11-25 Syngen Biotech Co.,Ltd. Composition of Streptococcus thermophilus from strain ST4 as an adjuvant of a chemotherapeutic agent for amelioration of diarrhea, appetite disorders and for weight maintenance
WO2023053828A1 (en) * 2021-09-30 2023-04-06 テルモ株式会社 Chemotherapy control device, chemotherapy control system, method for controlling chemotherapy control device, and chemotherapy control program
JP7323688B1 (en) 2022-08-25 2023-08-08 盈太企業股▲ふん▼有限公司 folding storage device

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI317636B (en) * 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
US8613962B2 (en) * 2007-08-31 2013-12-24 Kyushu University, National University Corporation Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent
TWI612902B (en) * 2009-11-30 2018-02-01 Meiji Co Ltd Use of a composition for manufacturing an improved intestinal functional composition and preparation method thereof
WO2012165345A1 (en) * 2011-05-27 2012-12-06 株式会社明治 Composition for preventing and/or ameliorating cancer-related irreversible metabolism disorders
WO2013080911A1 (en) * 2011-11-30 2013-06-06 株式会社明治 Nutritional composition for improving intestinal flora
HUE045997T2 (en) * 2012-05-31 2020-01-28 Univ Kinki Agent for preventing and/or treating peripheral neuropathic pain caused by anti-cancer drug
CN105705037A (en) * 2013-07-31 2016-06-22 株式会社明治 Nutritional composition for inhibiting growth of tumor
EP3135281B8 (en) * 2014-04-22 2020-12-23 Ajinomoto Co., Inc. Composition for preventing or improving peripheral neuropathy
SG11201610051YA (en) * 2014-06-25 2017-01-27 Meiji Co Ltd Ghrelin secretion promoter

Also Published As

Publication number Publication date
TW201817442A (en) 2018-05-16
CN109641027A (en) 2019-04-16
JP6325036B2 (en) 2018-05-16
JP2018027925A (en) 2018-02-22
TWI754662B (en) 2022-02-11
WO2018034345A1 (en) 2018-02-22

Similar Documents

Publication Publication Date Title
PH12017502181A1 (en) Nutritional compositions containing an elevated level of inositol and uses thereof
SG11201900960WA (en) Composition for ameliorating peripheral nerve disorder caused by anticancer agent
PH12018500090A1 (en) Nutritional compositions and methods for promoting cognitive development
MX2021004999A (en) Administration of butyrate, bete-hydroxybutyrate, cannabidiol, and related compounds in humans.
MA39157A1 (en) Composition useful for promoting female fertility
PH12016501952A1 (en) Nutritional compositions directed to subjects having cow`s milk protein allergies
BR112018003474A2 (en) lactobacillus fermentum bacteria that reduce acetaldehyde concentration
EA202091366A1 (en) DISCOLORED Rapeseed Protein Isolate
MY183250A (en) Pediatric nutritional composition with milk peptides for healthy growth and development
CO2019011847A2 (en) Improved pea albumins, method of obtaining them and their applications
CL2021003169A1 (en) ARNI Constructs for Inhibiting Scap Expression and Methods of Using Them
WO2018105919A3 (en) Pomegranate beverage containing marine collagen and method for manufacturing same
MX2021004467A (en) Strained acidic reduced carbiohydrate dairy products.
BR112018000682A2 (en) Process for the preparation of a fermented milk product
PH12018502207A1 (en) Methods of manufacturing nutritional formulations
PH12018500166A1 (en) Synthetic nutrional compostions tailored for infants of specific ages, and nutritional systems comprising them
MX2016007635A (en) Array of age-tailored infant formula with optimum protein content and lactose content.
PH12018500164A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
PH12018500165A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
PH12016501390A1 (en) Nutritional compositions containing ceramide
MX2016016313A (en) Food supplement based on ethyl ferulate.
Яковлева Ekaterina Yakovleva
PH12018500168A1 (en) Gender specific synthetic nutritional compositions and nutritional systems comprising them
TH76152S1 (en) Needle for solution
CO2018011578A1 (en) Alquernat livol food product for animals comprising inulin and chlorogenic acid and procedure for obtaining them